Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Erythropoietin receptors: their role beyond erythropoiesis.

× No keyword cloud information.

19 in total

1. Extended and stable gene expression via nucleofection of MIDGE construct into adult human marrow mesenchymal stromal cells.

Authors: P L Mok; S K Cheong; C F Leong; K H Chua; O Ainoon
Journal: Cytotechnology Date: 2011-12-10 Impact factor: 2.058

2. Erythropoietin pharmacokinetic/pharmacodynamic analysis suggests higher doses in treating neonatal anemia.

Authors: Srividya Neelakantan; John A Widness; Robert L Schmidt; Peter Veng-Pedersen
Journal: Pediatr Int Date: 2009-02 Impact factor: 1.524

3. Effects of erythropoietin receptor activity on angiogenesis, tubular injury, and fibrosis in acute kidney injury: a "U-shaped" relationship.

Authors: Mingjun Shi; Brianna Flores; Peng Li; Nancy Gillings; Kathryn L McMillan; Jianfeng Ye; Lily Jun-Shen Huang; Sachdev S Sidhu; Yong-Ping Zhong; Maria T Grompe; Philip R Streeter; Orson W Moe; Ming Chang Hu
Journal: Am J Physiol Renal Physiol Date: 2017-11-29

Review 4. Emerging erythropoiesis-stimulating agents.

Authors: Robert N Foley
Journal: Nat Rev Nephrol Date: 2010-02-23 Impact factor: 28.314

5. EPO improves the proliferation and inhibits apoptosis of trophoblast and decidual stromal cells through activating STAT-5 and inactivating p38 signal in human early pregnancy.

Authors: Yu Qing Ji; Yu Quan Zhang; Ming Qing Li; Mei Rong Du; Wei Wei Wei; Da Jin Li
Journal: Int J Clin Exp Pathol Date: 2011-11-03

6. TRPC3 activation by erythropoietin is modulated by TRPC6.

Authors: Iwona Hirschler-Laszkiewicz; Qin Tong; Kathleen Conrad; Wenyi Zhang; Wesley W Flint; Alistair J Barber; Dwayne L Barber; Joseph Y Cheung; Barbara A Miller
Journal: J Biol Chem Date: 2008-12-13 Impact factor: 5.157

7. Increased erythropoietin elimination in fetal sheep following chronic phlebotomy.

Authors: Kevin J Freise; John A Widness; Jeffrey L Segar; Robert L Schmidt; Peter Veng-Pedersen
Journal: Pharm Res Date: 2007-04-25 Impact factor: 4.200

Review 8. Erythropoietin: physiology and molecular mechanisms.

Authors: Robert N Foley
Journal: Heart Fail Rev Date: 2008-01-31 Impact factor: 4.214

9. Asialoerythropoietin prevents contrast-induced nephropathy.

Authors: Yukiyo Yokomaku; Toshiro Sugimoto; Shinji Kume; Shin-ichi Araki; Keiji Isshiki; Masami Chin-Kanasaki; Masayoshi Sakaguchi; Norihisa Nitta; Masakazu Haneda; Daisuke Koya; Takashi Uzu; Atsunori Kashiwagi
Journal: J Am Soc Nephrol Date: 2008-01-09 Impact factor: 10.121

10. Soluble erythropoietin receptor contributes to erythropoietin resistance in end-stage renal disease.

Authors: Eliyahu V Khankin; Walter P Mutter; Hector Tamez; Hai-Tao Yuan; S Ananth Karumanchi; Ravi Thadhani
Journal: PLoS One Date: 2010-02-16 Impact factor: 3.240